Provides Electronic Health Record (EHR) systems for managing patient medical records. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 5% a year over the last 4 years. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 2.5× for every dollar of annual revenue.
Analysts' average target sits 0% above today's price.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The company sells $653.2M a year; the problem isn’t sales — it’s costs running above that number.
A loss of $2.7M against $653.2M in annual sales.
The price action doesn’t yet back an upward turn. Council score: 0/10.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.